Edition:
United Kingdom

Mesoblast Ltd (MESO.OQ)

MESO.OQ on NASDAQ Stock Exchange Global Select Market

4.82USD
16 Jan 2019
Change (% chg)

$0.10 (+2.12%)
Prev Close
$4.72
Open
$4.76
Day's High
$4.96
Day's Low
$4.76
Volume
6,769
Avg. Vol
14,990
52-wk High
$8.74
52-wk Low
$3.35

Chart for

About

Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced... (more)

Overall

Beta: 2.53
Market Cap(Mil.): $568.33
Shares Outstanding(Mil.): 94.09
Dividend: --
Yield (%): --

Financials

  MESO.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -1.00 -- --
ROI: -12.06 8.99 14.96
ROE: -14.70 10.13 16.53

Earnings vs. Estimates